Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-09-11, Stock:LLY, The news for the past five days is as follows:
2020-09-03: NEWS1: Eli Lilly (LLY) Stock Moves -0.35%: What You Should Know.NEWS2: FDA approves additional doses of Trulicity® (dulaglutide) for the treatment of type 2 diabetes.NEWS3: Why Morgan Stanley Is Buying The Dip In Eli Lilly.NEWS4: A Trio of Stock Picks for the Value Investor.NEWS5: Merck CEO sees human trials for COVID-19 vaccine candidate 'fairly soon'.NEWS6: Morgan Stanley Turns Bullish On Eli Lilly, Lifts PT.NEWS7: How Much Did Eli Lilly's (NYSE:LLY) CEO Pocket Last Year?.NEWS8: The Blockbuster Drug That Could Pay Off Big for Eli Lilly.NEWS9: Pfizer targets end of October for COVID-19 vaccine update.
2020-09-04: NEWS1: Lilly (LLY) Gets FDA Approval for Higher Doses of Trulicity.NEWS2: The Daily Biotech Pulse: AbbVie In-licenses I-Mab's Cancer Drug, Savara Pulls The Plug On Cystic Fibrosis Study.
2020-09-08: NEWS1: COVID-19 vaccine safety pledge will make 'huge difference': Doctor.NEWS2: S.Korea's Celltrion to begin commercial production of COVID-19 antibody drug.
2020-09-09: NEWS1: Eli Lilly (LLY) Gains But Lags Market: What You Should Know.NEWS2: Regeneron expects to report biomarker data for COVID-19 therapy by September end.NEWS3: 2 Coronavirus Treatment Stocks to Buy Right Now.NEWS4: Lilly Announces Leadership Changes.
2020-09-10: NEWS1: Lilly Announces Webcast to Discuss ESMO 2020 Presentations.NEWS2: Regeneron’s Virus Treatment Has Probably Missed the Bus.NEWS3: Lilly commits Insulin Value Program, featuring $35 copay card, to suite of affordability solutions for people with diabetes.NEWS4: Lilly Oncology to Showcase New Data from Robust Cancer Research Pipeline at ESMO Virtual Congress 2020.

Answer: Rise